| 000 | 00618nam a2200217Ia 4500 | ||
|---|---|---|---|
| 005 | 20260808125504.0 | ||
| 008 | 260808s9999||||xx |||||||||||||| ||und|| | ||
| 020 | _a0-8247-8027-2 | ||
| 035 | _a6130 | ||
| 041 | _aENG | ||
| 082 | _a615.384 | ||
| 100 | _aChang, T. M. S. (ed.) | ||
| 245 | 0 | _aBlood substitutes | |
| 260 |
_aNew York _bMarcel and Dekker Incorporation _c1989 |
||
| 300 | _axv + 716 | ||
| 500 | _a9831 / 26.09.1990 | ||
| 505 | _aclinical pathology, therapeutic monitoring, drug analysis | ||
| 650 |
_aClinical Pathology _bPharmacology -- Therapeutics |
||
| 700 | _aGeyer, R. P. (ed.) | ||
| 942 | _cBK | ||
| 999 |
_c6128 _d6128 |
||